To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Immatics to merge with Arya
Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company, has agreed to merge with Arya Sciences Acquisition Corp, a blank check company backed by Perceptive Advisors.
